Enhancing the understanding of doxorubicin’s therapeutic impact in breast cancer
Crossref DOI link: https://doi.org/10.1007/s12032-024-02565-5
Published Online: 2024-11-15
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Zhuang, Ziye
Wang, Rui
Chi, Hao
Text and Data Mining valid from 2024-11-15
Version of Record valid from 2024-11-15
Article History
Received: 17 October 2024
Accepted: 10 November 2024
First Online: 15 November 2024
Declarations
:
: The authors declare no competing interests.